Artikel ; Online: Gene expression dynamics following mithramycin treatment: A possible model for post-chemotherapy cognitive impairment.
Clinical and experimental pharmacology & physiology
2018 Band 45, Heft 10, Seite(n) 1028–1037
Abstract: Chemotherapy-induced cognitive changes is a major burden on a substantial number of cancer survivors. The mechanism of this sequel is unknown. In this study, we followed long-term effects of early in life mithramycin (MTR) treatment on behaviour and on ... ...
Abstract | Chemotherapy-induced cognitive changes is a major burden on a substantial number of cancer survivors. The mechanism of this sequel is unknown. In this study, we followed long-term effects of early in life mithramycin (MTR) treatment on behaviour and on the normal course of alterations of gene expression in brain. Between post-natal days (PND) 7 and 10, male rats were divided into 2 groups, 1 receiving MTR (0.1 mg/kg s.c. per day) and the other receiving saline. At PND11, frontal cortex tissue samples were dissected from 4 rats from each group. At PND 65 the remaining rats underwent behavioural tests after which all the rats were decapitated and their prefrontal cortex incised. Rats treated transiently with MTR early in life, showed impairments in spatial working memory and anxious-like behaviour in adulthood. The immediate molecular effect of MTR was expressed in a limited number of altered genes of different unconnected trajectories, which were simultaneously distorted by the drug. In contrast, 3 months later we observed a change in the expression of more than 1000 genes that converged into specific cellular processes. Time-dependent gene expression dynamics of several genes was significantly different between treated and untreated rats. The differences in the total number of altered genes and in gene expression trends, immediately and long after MTR treatment cessation, suggest the evolution of a new cellular homeostatic set point, which can lead to behavioural abnormalities following chemotherapy treatment. |
---|---|
Mesh-Begriff(e) | Animals ; Anxiety/complications ; Cognitive Dysfunction/chemically induced ; Cognitive Dysfunction/complications ; Cognitive Dysfunction/genetics ; Cognitive Dysfunction/physiopathology ; Gene Expression Regulation/drug effects ; Male ; Memory, Short-Term/drug effects ; Phenotype ; Plicamycin/adverse effects ; Rats ; Spatial Memory/drug effects |
Chemische Substanzen | Plicamycin (NIJ123W41V) |
Sprache | Englisch |
Erscheinungsdatum | 2018-07-11 |
Erscheinungsland | Australia |
Dokumenttyp | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 189277-0 |
ISSN | 1440-1681 ; 0305-1870 ; 0143-9294 |
ISSN (online) | 1440-1681 |
ISSN | 0305-1870 ; 0143-9294 |
DOI | 10.1111/1440-1681.12975 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 990: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.